Neuroprotection and Anticonvulsant Properties: Studies suggest DSIP stabilizes neural activity, reduces excitotoxicity, and possesses anti-convulsant properties, potentially by potentiating the action of anti-epileptic drugs in seizure models
2012;28 Suppl 1:8-14
The prevalence of gastrointestinal adverse events underscores the importance of patient education before initiating semaglutide therapy, including strategies for minimizing discomfort and recognizing warning signs that merit medical attention
aunque la causalidad no est completamente establecida, se recomienda suspender el tratamiento y evaluar ante dolor abdominal severo
Get the results Frequently Asked Question In a 68week trial, weekly semaglutide 2.4 mg plus lifestyle produced clinically meaningful loss (results vary)
This article explains the evidence around stopping GLP-1 therapy, what to expect when treatment ends, and how to discontinue safely under medical supervision in line with UK clinical guidance